Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Daily Top 10 COVID-19 papers



  Free Subscription


1 Clin Infect Dis
5 Lancet
1 Lancet Glob Health
3 Lancet Infect Dis
2 N Engl J Med
3 PLoS One
1 Proc Natl Acad Sci U S A
3 Science
11 Vaccine

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Clin Infect Dis

  1. DIAZGRANADOS CA, Langevin E, Bonaparte M, Sridhar S, et al
    CYD-TDV dengue vaccine performance by baseline immune profile (monotypic/multitypic) in dengue seropositive individuals.
    Clin Infect Dis. 2020 Mar 21. pii: 5810750. doi: 10.1093.
    PubMed         Abstract available


    Leading HIV Vaccine Trial Stopped for Ineffectiveness.
    JAMA. 2020;323:1124.

  3. KOH HK, Gellin BG
    Measles as Metaphor-What Resurgence Means for the Future of Immunization.
    JAMA. 2020;323:914-915.


    Evaluation of a tetravalent dengue vaccine by serostatus and serotype.
    Lancet. 2020 Mar 17. pii: S0140-6736(20)30603.

  5. FIDLER S, Stohr W, Pace M, Dorrell L, et al
    Antiretroviral therapy alone versus antiretroviral therapy with a kick and kill approach, on measures of the HIV reservoir in participants with recent HIV infection (the RIVER trial): a phase 2, randomised trial.
    Lancet. 2020 Feb 18. pii: S0140-6736(19)32990.
    PubMed         Abstract available

    Hope for the Ebola outbreak in DR Congo.
    Lancet. 2020;395:773.

  7. TRICOU V, Saez-Llorens X, Yu D, Rivera L, et al
    Safety and immunogenicity of a tetravalent dengue vaccine in children aged 2-17 years: a randomised, placebo-controlled, phase 2 trial.
    Lancet. 2020 Mar 17. pii: S0140-6736(20)30556.
    PubMed         Abstract available

  8. BISWAL S, Borja-Tabora C, Martinez Vargas L, Velasquez H, et al
    Efficacy of a tetravalent dengue vaccine in healthy children aged 4-16 years: a randomised, placebo-controlled, phase 3 trial.
    Lancet. 2020 Mar 17. pii: S0140-6736(20)30414.
    PubMed         Abstract available

    Lancet Glob Health

  9. LUTTJEBOER J, Wondimu A, Van der Schans J, Postma MJ, et al
    Maximising the potential of HPV vaccines.
    Lancet Glob Health. 2020;8:e460-e461.

    Lancet Infect Dis

  10. BAVARI S, Iversen PL
    Chimpanzee adenovirus type 3 vectored Ebola vaccine: expanding the field.
    Lancet Infect Dis. 2020 Mar 19. pii: S1473-3099(20)30065.

  11. TAPIA MD, Sow SO, Ndiaye BP, Mbaye KD, et al
    Safety, reactogenicity, and immunogenicity of a chimpanzee adenovirus vectored Ebola vaccine in adults in Africa: a randomised, observer-blind, placebo-controlled, phase 2 trial.
    Lancet Infect Dis. 2020 Mar 19. pii: S1473-3099(20)30016.
    PubMed         Abstract available

  12. TAPIA MD, Sow SO, Mbaye KD, Thiongane A, et al
    Safety, reactogenicity, and immunogenicity of a chimpanzee adenovirus vectored Ebola vaccine in children in Africa: a randomised, observer-blind, placebo-controlled, phase 2 trial.
    Lancet Infect Dis. 2020 Mar 19. pii: S1473-3099(20)30019.
    PubMed         Abstract available

    N Engl J Med

  13. PITTMAN PR, Weidenthaler H, Chaplin P
    A Modified Vaccine against Smallpox. Reply.
    N Engl J Med. 2020;382:1285-1286.

  14. ENGLER R, Cooper LT
    A Modified Vaccine against Smallpox.
    N Engl J Med. 2020;382:1285.

    PLoS One

  15. NJOUOM R, Monamele CG, Munshili Njifon HL, Kenmoe S, et al
    Circulation of influenza virus from 2009 to 2018 in Cameroon: 10 years of surveillance data.
    PLoS One. 2019;14:e0225793.
    PubMed         Abstract available

  16. OGAWA T, Inoue T, Kasahara K, Konishi M, et al
    Impact of vaccination on measles, mumps, and rubella antibody titers in Japanese healthcare workers: An observational study.
    PLoS One. 2020;15:e0230329.
    PubMed         Abstract available

  17. HAO S, Wang C, Liu S, He J, et al
    HPV genotypic spectrum in Jilin province, China, where non-vaccine-covered HPV53 and 51 are prevalent, exhibits a bimodal age-specific pattern.
    PLoS One. 2020;15:e0230640.
    PubMed         Abstract available

    Proc Natl Acad Sci U S A

  18. TIAN M, McGovern K, Cheng HL, Waddicor P, et al
    Conditional antibody expression to avoid central B cell deletion in humanized HIV-1 vaccine mouse models.
    Proc Natl Acad Sci U S A. 2020 Mar 24. pii: 1921996117.
    PubMed         Abstract available


    Polio eradication campaign loses ground.
    Science. 2019;365:106-107.

  20. MACKLIN GR, O'Reilly KM, Grassly NC, Edmunds WJ, et al
    Evolving epidemiology of poliovirus serotype 2 following withdrawal of the type 2 oral poliovirus vaccine.
    Science. 2020 Mar 19. pii: science.aba1238. doi: 10.1126/science.aba1238.
    PubMed         Abstract available

    Ebola veteran promises an end to Congo's epidemic.
    Science. 2019;365:526-527.


  22. ASANTE KP, Ansong D, Kaali S, Adjei S, et al
    Immunogenicity and safety of the RTS,S/AS01 malaria vaccine co-administered with measles, rubella and yellow fever vaccines in Ghanaian children: A phase IIIb, multi-center, non-inferiority, randomized, open, controlled trial.
    Vaccine. 2020 Mar 16. pii: S0264-410X(20)30358.
    PubMed         Abstract available

  23. MURAKAMI K, Fujii Y, Someya Y
    Effects of the thermal denaturation of Sabin-derived inactivated polio vaccines on the D-antigenicity and the immunogenicity in rats.
    Vaccine. 2020 Mar 17. pii: S0264-410X(20)30380.
    PubMed         Abstract available

  24. QAMAR FN, Yousafzai MT, Khaliq A, Karim S, et al
    Adverse events following immunization with typhoid conjugate vaccine in an outbreak setting in Hyderabad, Pakistan.
    Vaccine. 2020 Mar 19. pii: S0264-410X(20)30383.
    PubMed         Abstract available

  25. SANDO E, Suzuki M, Furumoto A, Asoh N, et al
    Corrigendum to "Impact of the pediatric 13-valent pneumococcal conjugate vaccine on serotype distribution and clinical characteristics of pneumococcal pneumonia in adults: The Japan Pneumococcal Vaccine Effectiveness Study (J-PAVE)" [Vaccine 37 (2019)
    Vaccine. 2020 Mar 19. pii: S0264-410X(20)30397.

  26. WOESTENBERG PJ, van Benthem BHB, Bogaards JA, King AJ, et al
    HPV infections among young MSM visiting sexual health centers in the Netherlands: Opportunities for targeted HPV vaccination.
    Vaccine. 2020 Mar 19. pii: S0264-410X(20)30330.
    PubMed         Abstract available

  27. IKILEZI G, Augusto OJ, Sbarra A, Sherr K, et al
    Determinants of geographical inequalities for DTP3 vaccine coverage in sub-Saharan Africa.
    Vaccine. 2020 Mar 20. pii: S0264-410X(20)30338.
    PubMed         Abstract available

  28. WILSON-WELDER JH, Boggiatto P, Nally JE, Wafa EI, et al
    Bovine immune response to leptospira antigen in different novel adjuvants and vaccine delivery platforms.
    Vaccine. 2020 Mar 20. pii: S0264-410X(20)30333.
    PubMed         Abstract available

  29. SUO L, Lu L, Zhao D, Pang X, et al
    Impact of a 2-dose voluntary vaccination strategy on varicella epidemiology in Beijing, 2011-2017.
    Vaccine. 2020 Mar 20. pii: S0264-410X(20)30140.
    PubMed         Abstract available

  30. O'LEARY ST, Cataldi JR, Lindley MC, Hurley LP, et al
    Impact of media reports regarding influenza vaccine on obstetricians' vaccination practices.
    Vaccine. 2020 Mar 21. pii: S0264-410X(20)30263.
    PubMed         Abstract available

  31. DAYAN GH, Langevin E, Gilbert PB, Wu Y, et al
    Assessment of the long-term efficacy of a dengue vaccine against symptomatic, virologically-confirmed dengue disease by baseline dengue serostatus.
    Vaccine. 2020 Mar 20. pii: S0264-410X(20)30384.
    PubMed         Abstract available

  32. CHANG LJ, Hedrick J, Christensen S, Pan J, et al
    A Phase II, randomized, immunogenicity and safety study of a quadrivalent meningococcal conjugate vaccine, MenACYW-TT, in healthy adolescents in the United States.
    Vaccine. 2020 Mar 21. pii: S0264-410X(20)30370.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.